Skip to main content
. 2019 Nov 22;8(4):258. doi: 10.3390/pathogens8040258

Figure 4.

Figure 4

Germacrone inhibits PRV replication at an early stage. (A) Outline of the experiment. (B) Vero cells were infected with PRV (MOI 0.1), followed by treatment with 150 μM of germacrone at the indicated time (hpi). DMSO was used as a control. Virus titers were determined at 24 hpi. Data are presented as the mean ± SD from triplicate samples. All the results were confirmed by three independent experiments (*** p < 0.001).